Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study

被引:16
|
作者
Hag-Yahia, Nasreen [1 ]
Gemer, Ofer [2 ]
Eitan, Ram [3 ]
Raban, Oded [3 ]
Vaknin, Zvi [4 ]
Levy, Tally [5 ]
Leytes, Sofia [5 ]
Lavie, Ofer [6 ]
Ben-Arie, Alon [7 ]
Amit, Amnon [8 ]
Namazov, Ahmed [2 ]
Volodarsky, Michael [2 ]
Ben-Shachar, Inbar [9 ]
Atlas, Ilan [10 ]
Bruchim, Ilan [11 ]
Kadan, Yfat [1 ]
Helpman, Limor [1 ,12 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Univ Med Ctr, Dept Obstet & Gynecol, Ashqelon, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Rabin Med Ctr, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Assaf Haroffe Med Ctr, Zerifin, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Dept Obstet & Gynecol, Wolfson Med Ctr, Holon, Israel
[6] Technion, Rappaport Fac Med, Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[7] Hebrew Univ Jerusalem, Dept Obstet & Gynecol, Kaplan Med Ctr, Rehovot, Israel
[8] Technion, Rappaport Fac Med, Rambam Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[9] Bar Ilan Univ, Dept Obstet & Gynecol, Ziv Med Ctr, Safed, Israel
[10] Bar Ilan Univ, Poriya Med Ctr, Dept Obstet & Gynecol, Tiberias, Israel
[11] Technion, Rappaport Fac Med, Hillel Yaffe Med Ctr, Dept Obstet & Gynecol, Hadera, Israel
[12] McMaster Univ, Div Gynecol Oncol, Juravinski Canc Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada
关键词
age; endometrial cancer; older adults; older women; uterine cancer; ELDERLY-WOMEN; OPEN-LABEL; SURGERY; MANAGEMENT; CARCINOMA; SURVIVAL; IMPACT; RADIOTHERAPY; MORBIDITY; CHEMOTHERAPY;
D O I
10.1111/aogs.14015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction Advanced age is considered an adverse factor in endometrial cancers but may be a surrogate for other conditions that impact outcomes. The study objective was to assess the association of age with endometrial cancer features, treatment and prognosis. Material and methods In this multicenter cohort study, consecutive women with endometrial cancer treated at 10 Israeli institutions between 2000 and 2014 were accrued in an assimilated database. Postmenopausal women were stratified into age groups with a cut-off of 80. Clinical, pathological and treatment data were compared using t test or Mann-Whitney test for continuous variables, and Chi-square Test or Fisher's Exact test for categorical variables. Main outcome measures included disease recurrence and disease-specific and overall survival; these were plotted using the Kaplan-Meier method and compared using the log-rank test. The association between age and recurrence and survival, adjusted for other clinical and pathological factors, was assessed using multivariable Cox regression modeling. Results A total of 1764 postmenopausal women with endometrial cancer were identified. Adverse pathological features were more prevalent in older women, including high-risk histologies (35% vs 27%, P = .025), deep myoinvasion (44% vs 29%, P = .001) and lymphovascular involvement (22% vs 15%, P = .024). Surgical staging was performed less frequently among older women (33% vs 56%; P < .001). Chemotherapy was less often prescribed, even for non-endometrioid histologies (72% vs 45%; P < .001). On multivariable analysis, age remained a significant predictor for recurrence (HR = 1.75, P = .007), death of disease (HR = 1.89, P = .003) and death (HR = 2.4, P < .001). Conclusions Older age in women with endometrial cancer is associated with more adverse disease features, limited surgery and adjuvant treatment, and worse outcomes. On multivariable analysis, age remains an independent prognosticator in this population.
引用
收藏
页码:444 / 452
页数:9
相关论文
共 50 条
  • [21] Connexin 43 is an independent predictor of patient outcome in breast cancer patients
    Maria Chasampalioti
    Andrew R. Green
    Ian O. Ellis
    Emad A. Rakha
    Andrew M. Jackson
    Ian Spendlove
    Judith M. Ramage
    Breast Cancer Research and Treatment, 2019, 174 : 93 - 102
  • [22] Connexin 43 is an independent predictor of patient outcome in breast cancer patients
    Chasampalioti, Maria
    Green, Andrew R.
    Ellis, Ian O.
    Rakha, Emad A.
    Jackson, Andrew M.
    Spendlove, Ian
    Ramage, Judith M.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (01) : 93 - 102
  • [23] Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria
    Kong, Tae Wook
    Chang, Suk-Joon
    Paek, Jiheum
    Lee, Yonghee
    Chun, Mison
    Ryu, Hee-Sug
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (01) : 32 - +
  • [24] Sexual Function of Patients With Endometrial Cancer Enrolled in the Gynecologic Oncology Group LAP2 Study
    Carter, Jeanne
    Huang, Helen
    Chase, Dana M.
    Walker, Joan L.
    Cella, David
    Wenzel, Lari
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1624 - 1633
  • [25] HER-2 is an independent prognostic factor in endometrial cancer: Association with outcome in a large cohort of surgically staged patients
    Morrison, C
    Zanagnolo, V
    Ramirez, N
    Cohn, DE
    Kelbick, N
    Copeland, L
    Maxwell, LG
    Fowler, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2376 - 2385
  • [26] Loneliness as a predictor of mortality in cancer patients, a cohort study
    Valdelamar, Adriana
    de la Hoz, Fernando
    Sanchez, Ricardo
    BIOMEDICA, 2024, 44 : 119 - 138
  • [28] The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group study
    McMeekin, D. Scott
    Filiaci, Virginia L.
    Thigpen, J. Tate
    Gallion, Holly H.
    Fleming, Gini F.
    Rodgers, William H.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 16 - 22
  • [29] Plan complexity as an independent outcome predictor of lung cancer patients treated with SBRT
    Li, C.
    Shen, J.
    Shi, A.
    Zhang, Y.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S992 - S994
  • [30] The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients
    Khoshnaw, Sarkawt M.
    Rakha, Emad A.
    Abdel-Fatah, Tarek
    Nolan, Christopher C.
    Hodi, Zsolt
    Macmillan, R. Douglas
    Ellis, Ian O.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 139 - 153